CGRP Signaling via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid Leukemia
The neuropeptide CGRP, acting through the G-protein coupled receptor CALCRL and its coreceptor RAMP1, plays a key role in migraines, which has led to the clinical development of several inhibitory compounds. Recently, high <i>CALCRL</i> expression has been shown to be associated with a p...
Main Authors: | Tobias Gluexam, Alexander M. Grandits, Angela Schlerka, Chi Huu Nguyen, Julia Etzler, Thomas Finkes, Michael Fuchs, Christoph Scheid, Gerwin Heller, Hubert Hackl, Nathalie Harrer, Heinz Sill, Elisabeth Koller, Dagmar Stoiber, Wolfgang Sommergruber, Rotraud Wieser |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/23/5826 |
Similar Items
-
CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
by: Valentina Favoni, et al.
Published: (2019-03-01) -
Bifidobacterium bifidum does not show cell toxicity on leukemic cells of AML patients but induced cell death on K562 cell line
by: Nazanin Ghadimi, et al.
Published: (2020-09-01) -
Antagoniści CGRP w leczeniu napadów migreny
by: Marcin Kopka
Published: (2018-10-01) -
New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies
by: Damiana Scuteri, et al.
Published: (2019-04-01) -
Blocking CGRP in migraine patients – a review of pros and cons
by: Marie Deen, et al.
Published: (2017-09-01)